Premium Research Peptides • Purity Verified, Laboratory Focused!

Premium Research Peptides • Purity Verified, Laboratory Focused!

WOLVERINE – 20MG

$110.00

COA Provided 3rd-Party Tested

Total Peptide Content: BPC-157 / TB-500 (10mg / 10 mg) | 20 mg per vial.

  • Dual-peptide research blend (BPC-157 / 10mg + TB-500 / 10mg) studied in tissue protection and regenerative signaling models

  • BPC-157 is associated with angiogenic pathways, collagen organization, and microvascular signaling research

  • TB-500 is explored for its role in cell migration, actin regulation, and soft-tissue signaling pathways

  • Common research focus includes musculoskeletal models, tendon and ligament research, and recovery-related signaling dynamics

Supplied as a lyophilized powder for laboratory research use only.

Vials Quantity Discount
Buy 3, Get 5% OFF 3 5%
Buy 5, Get 10% OFF 5 10%
Buy 6+, Get 15% OFF 6 – 9 15%

$110.00

Out of stock

By adding this item to your cart, you confirm that all information provided is accurate and that all products currently listed on this site are for research purposes only. You acknowledge that improper handling or use may pose serious risks and that OptimalPep reserves the right to verify information and cancel orders when necessary.

Description:

Wolverine — Dual-Peptide Research Formulation (BPC-157 + TB-500)

Wolverine is a dual-peptide research formulation combining BPC-157 and TB-500 (Thymosin Beta-4 fragment) into a single lyophilized vial. This consolidated format preserves the full 20 mg total peptide content10 mg BPC-157 and 10 mg TB-500—while enabling investigation of complementary tissue-signaling pathways within a unified research system.

BPC-157 is a gastric-derived pentadecapeptide fragment studied in preclinical research for its involvement in tissue protection, angiogenic signaling, microvascular integrity, and inflammatory pathway modulation. Research frequently examines its relationship to nitric-oxide signaling, epithelial stability, and cytokine balance across a range of experimental models.

TB-500 (Thymosin Beta-4 fragment) is a synthetic peptide corresponding to the active region of the naturally occurring actin-binding protein thymosin beta-4. In laboratory settings, TB-500 is evaluated for its role in cellular migration, cytoskeletal organization, and extracellular matrix (ECM) remodeling, particularly in models focused on tissue repair dynamics.

When combined, BPC-157 and TB-500 present complementary mechanisms of research interest: BPC-157 contributing to vascular stability and inflammatory signaling, and TB-500 supporting actin-mediated cell motility and structural reorganization. This pairing is frequently explored in preclinical research assessing coordinated tissue-repair signaling and potential additive or synergistic pathway interactions.

Research areas of interest include:

  • Musculoskeletal and connective-tissue models, including muscle, tendon, and ligament research
  • Angiogenesis and microvascular studies examining vascular support mechanisms
  • Cytoskeletal and cellular-migration investigations involving fibroblast and endothelial cells
  • Inflammatory-response signaling, including cytokine and tissue-stress pathways
  • Wound-healing and tissue-regeneration models focused on ECM organization and remodeling

Intended Use:

For laboratory research use only. Not for human or veterinary use.

COA (Certificate of Analysis)

Related Products:

You must be at least 18+ to visit this site.

By enterting this site, you are accepting our Terms & Conditions.

By using this site, you acknowledge that all products and information are provided for research purposes only and are not intended for human consumption or medical use.

2